gabapentin

Generic: gabapentin

Labeler: marksans pharma limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name gabapentin
Generic Name gabapentin
Labeler marksans pharma limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

gabapentin 400 mg/1

Manufacturer
MARKSANS PHARMA LIMITED

Identifiers & Regulatory

Product NDC 25000-105
Product ID 25000-105_a09d9505-f432-4ed6-b274-3885faffb02a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090007
Listing Expiration 2026-12-31
Marketing Start 2011-02-28

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 25000105
Hyphenated Format 25000-105

Supplemental Identifiers

RxCUI
310430 310431 310432
UPC
0325000105129 0325000105037
UNII
6CW7F3G59X
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gabapentin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number ANDA090007 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 400 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (25000-105-03)
  • 500 CAPSULE in 1 BOTTLE (25000-105-12)
  • 1000 CAPSULE in 1 BOTTLE (25000-105-14)
source: ndc

Packages (3)

Ingredients (1)

gabapentin (400 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a09d9505-f432-4ed6-b274-3885faffb02a", "openfda": {"nui": ["N0000008486"], "upc": ["0325000105129", "0325000105037"], "unii": ["6CW7F3G59X"], "rxcui": ["310430", "310431", "310432"], "spl_set_id": ["98bb408d-c402-4da6-8f9d-5de4833dedc4"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["MARKSANS PHARMA LIMITED"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (25000-105-03)", "package_ndc": "25000-105-03", "marketing_start_date": "20110228"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (25000-105-12)", "package_ndc": "25000-105-12", "marketing_start_date": "20110228"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (25000-105-14)", "package_ndc": "25000-105-14", "marketing_start_date": "20210916"}], "brand_name": "GABAPENTIN", "product_id": "25000-105_a09d9505-f432-4ed6-b274-3885faffb02a", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "25000-105", "generic_name": "GABAPENTIN", "labeler_name": "MARKSANS PHARMA LIMITED", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GABAPENTIN", "active_ingredients": [{"name": "GABAPENTIN", "strength": "400 mg/1"}], "application_number": "ANDA090007", "marketing_category": "ANDA", "marketing_start_date": "20110228", "listing_expiration_date": "20261231"}